MediciNova Inc. (MNOV)

9.45
0.17 1.77
NASDAQ : Health Technology
Prev Close 9.62
Open 9.60
Day Low/High 9.34 / 9.60
52 Wk Low/High 4.40 / 14.50
Volume 107.16K
Avg Volume 239.80K
Exchange NASDAQ
Shares Outstanding 41.13M
Market Cap 406.35M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Interesting MNOV Put Options For February 16th

Interesting MNOV Put Options For February 16th

Investors in Medicinova Inc saw new options become available this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNOV options chain for the new February 16th contracts and identified the following put contract of particular interest.

Commit To Purchase Medicinova At $5, Earn 10% Annualized Using Options

Commit To Purchase Medicinova At $5, Earn 10% Annualized Using Options

Investors considering a purchase of Medicinova Inc shares, but cautious about paying the going market price of $7.32/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $5 strike, which has a bid at the time of this writing of 25 cents.

Versartis Drops on Q3 Numbers, Hires Adviser -- Biotech Movers

Versartis Drops on Q3 Numbers, Hires Adviser -- Biotech Movers

The Menlo Park, Calif.-based firm on Thursday reported third-quarter results and said it has hired Cowen to help with evaluating potential transactions.

Insider Bets Paying Off At MNOV As New 52-Week High Reached

Insider Bets Paying Off At MNOV As New 52-Week High Reached

In trading on Thursday, shares of Medicinova Inc touched a new 52-week high of $7.85/share. That's a 78.41% rise, or $3.45 per share from the 52-week low of $4.40 set back on 08/11/2017.

Celgene Falls After Updates to 2017 Guidance, 2020 Targets -- Biotech Movers

Celgene Falls After Updates to 2017 Guidance, 2020 Targets -- Biotech Movers

The Summit, N.J.-based firm on Oct. 26 unveiled third-quarter results and updated its 2017 outlook and financial targets for 2020.

Commit To Buy Medicinova At $5, Earn 131.7% Annualized Using Options

Commit To Buy Medicinova At $5, Earn 131.7% Annualized Using Options

Investors considering a purchase of Medicinova Inc shares, but cautious about paying the going market price of $6.57/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $5 strike, which has a bid at the time of this writing of 65 cents.